• Je něco špatně v tomto záznamu ?

Search for AL amyloidosis risk factors using Mendelian randomization

CN. Saunders, S. Chattopadhyay, S. Huhn, N. Weinhold, P. Hoffmann, MM. Nöthen, KH. Jöckel, B. Schmidt, S. Landi, H. Goldschmidt, P. Milani, G. Merlini, D. Rowcieno, P. Hawkins, U. Hegenbart, G. Palladini, A. Wechalekar, SO. Schönland, A. Försti,...

. 2021 ; 5 (13) : 2725-2731. [pub] 20210713

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025363

Grantová podpora
C1298/A8362 Cancer Research UK - United Kingdom

In amyloid light chain (AL) amyloidosis, amyloid fibrils derived from immunoglobulin light chain are deposited in many organs, interfering with their function. The etiology of AL amyloidosis is poorly understood. Summary data from genome-wide association studies (GWASs) of multiple phenotypes can be exploited by Mendelian randomization (MR) methodology to search for factors influencing AL amyloidosis risk. We performed a 2-sample MR analyzing 72 phenotypes, proxied by 3461 genetic variants, and summary genetic data from a GWAS of 1129 AL amyloidosis cases and 7589 controls. Associations with a Bonferroni-defined significance level were observed for genetically predicted increased monocyte counts (P = 3.8 × 10-4) and the tumor necrosis factor receptor superfamily member 17 (TNFRSF17) gene (P = 3.4 × 10-5). Two other associations with the TNFRSF (members 6 and 19L) reached a nominal significance level. The association between genetically predicted decreased fibrinogen levels may be related to roles of fibrinogen other than blood clotting. be related to its nonhemostatic role. It is plausible that a causal relationship with monocyte concentration could be explained by selection of a light chain-producing clone during progression of monoclonal gammopathy of unknown significance toward AL amyloidosis. Because TNFRSF proteins have key functions in lymphocyte biology, it is entirely plausible that they offer a potential link to AL amyloidosis pathophysiology. Our study provides insight into AL amyloidosis etiology, suggesting high circulating levels of monocytes and TNFRSF proteins as risk factors.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025363
003      
CZ-PrNML
005      
20211026133904.0
007      
ta
008      
211013s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1182/bloodadvances.2021004423 $2 doi
035    __
$a (PubMed)34228109
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Saunders, Charlie N $u Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom
245    10
$a Search for AL amyloidosis risk factors using Mendelian randomization / $c CN. Saunders, S. Chattopadhyay, S. Huhn, N. Weinhold, P. Hoffmann, MM. Nöthen, KH. Jöckel, B. Schmidt, S. Landi, H. Goldschmidt, P. Milani, G. Merlini, D. Rowcieno, P. Hawkins, U. Hegenbart, G. Palladini, A. Wechalekar, SO. Schönland, A. Försti, R. Houlston, K. Hemminki
520    9_
$a In amyloid light chain (AL) amyloidosis, amyloid fibrils derived from immunoglobulin light chain are deposited in many organs, interfering with their function. The etiology of AL amyloidosis is poorly understood. Summary data from genome-wide association studies (GWASs) of multiple phenotypes can be exploited by Mendelian randomization (MR) methodology to search for factors influencing AL amyloidosis risk. We performed a 2-sample MR analyzing 72 phenotypes, proxied by 3461 genetic variants, and summary genetic data from a GWAS of 1129 AL amyloidosis cases and 7589 controls. Associations with a Bonferroni-defined significance level were observed for genetically predicted increased monocyte counts (P = 3.8 × 10-4) and the tumor necrosis factor receptor superfamily member 17 (TNFRSF17) gene (P = 3.4 × 10-5). Two other associations with the TNFRSF (members 6 and 19L) reached a nominal significance level. The association between genetically predicted decreased fibrinogen levels may be related to roles of fibrinogen other than blood clotting. be related to its nonhemostatic role. It is plausible that a causal relationship with monocyte concentration could be explained by selection of a light chain-producing clone during progression of monoclonal gammopathy of unknown significance toward AL amyloidosis. Because TNFRSF proteins have key functions in lymphocyte biology, it is entirely plausible that they offer a potential link to AL amyloidosis pathophysiology. Our study provides insight into AL amyloidosis etiology, suggesting high circulating levels of monocytes and TNFRSF proteins as risk factors.
650    12
$a amyloidóza $x genetika $7 D000686
650    _2
$a celogenomová asociační studie $7 D055106
650    _2
$a lidé $7 D006801
650    12
$a primární amyloidóza $7 D000075363
650    _2
$a mendelovská randomizace $7 D057182
650    _2
$a rizikové faktory $7 D012307
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Chattopadhyay, Subhayan $u Department of Clinical Genetics, Lund University, Lund, Sweden
700    1_
$a Huhn, Stefanie $u Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
700    1_
$a Weinhold, Niels $u Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
700    1_
$a Hoffmann, Per $u Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany $u Department of Biomedicine, University of Basel, Basel, Switzerland
700    1_
$a Nöthen, Markus M $u Institute of Human Genetics, University of Bonn, School of Medicine and University Hospital Bonn, Bonn, Germany
700    1_
$a Jöckel, Karl-Heinz $u Institute for Medical Informatics, Biometry, and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
700    1_
$a Schmidt, Börge $u Institute for Medical Informatics, Biometry, and Epidemiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
700    1_
$a Landi, Stefano $u Department of Biology, University of Pisa, Pisa, Italy
700    1_
$a Goldschmidt, Hartmut $u Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany $u National Centre of Tumor Diseases, Heidelberg, Germany
700    1_
$a Milani, Paolo $u Amyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo" and Department of Molecular Medicine, University of Pavia, Pavia, Italy
700    1_
$a Merlini, Giampaolo $u Amyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo" and Department of Molecular Medicine, University of Pavia, Pavia, Italy
700    1_
$a Rowcieno, Dorota $u National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, United Kingdom
700    1_
$a Hawkins, Philip $u National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, United Kingdom
700    1_
$a Hegenbart, Ute $u Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
700    1_
$a Palladini, Giovanni $u Amyloidosis Research and Treatment Center, Foundation "Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo" and Department of Molecular Medicine, University of Pavia, Pavia, Italy
700    1_
$a Wechalekar, Ashutosh $u National Amyloidosis Centre, University College London Medical School, Royal Free Hospital Campus, London, United Kingdom
700    1_
$a Schönland, Stefan O $u Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany
700    1_
$a Försti, Asta $u Hopp Children's Cancer Center, Heidelberg, Germany $u Division of Pediatric Neuro-oncology, German Cancer Research Center, German Cancer Consortium, Heidelberg, Germany
700    1_
$a Houlston, Richard $u Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom
700    1_
$a Hemminki, Kari $u Biomedical Center, Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Pilsen, Czech Republic; and $u Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany
773    0_
$w MED00194912 $t Blood advances $x 2473-9537 $g Roč. 5, č. 13 (2021), s. 2725-2731
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34228109 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133910 $b ABA008
999    __
$a ok $b bmc $g 1714415 $s 1145870
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 5 $c 13 $d 2725-2731 $e 20210713 $i 2473-9537 $m Blood advances $n Blood Adv $x MED00194912
GRA    __
$a C1298/A8362 $p Cancer Research UK $2 United Kingdom
LZP    __
$a Pubmed-20211013

Najít záznam

Citační ukazatele

Možnosti archivace